References
- Miyazaki M, Yamamoto K. Synthetic phosphatidylethanolamines as renin inhibitor. Proc Soc exp Biol Med 1977; 155: 468–473
- Rigger A JL, Lever A F, Miliar J A, Morton J J, Slack B. Correlation of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors. Lancet 1977; 2: 1317–1319
- Swales J D, Loudon M, Bing R F, Thurston H. Renin in the arterial wall. Clin Exp Hypertens [A] 1983; 5: 1127–1136
- Gould A B, Skeggs L T, Kahan J R. The presence of renin activity in blood vessel walls. J Exp Med 1964; 119: 389–399
- Okamura T, Miyazaki M, Inagami T, Toda N. Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension 1986; 8: 560–565
- Iso T, Yamauchi H, Suda H, Nakata K, Nishimura K, Iwao J. A new potent inhibitor of converting enzyme (2R, 4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl) 4-thiazolidine-carboxylic acid (SA 446). Jpn J Pharmacol 1981; 31: 875–882
- Ryan J W, Ryan U S, Schultz D R, Whitaker C, Chung A. Subcellular localization of pulmonary angiotensin-converting enzyme(kininase II). Biochem J 1975; 146: 497–499
- Caldwell P RB, Seegal B C, Hsu K C, Das M, Soffer R L. Angiotensin-converting enzyme vascular endothelial localization. Science 1976; 191: 1050–1051
- Okunishi H, Miyazaki M, Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertension 1984; 2: 277–284
- Cushman D W, Cheung H S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971; 20: 1637–1648
- Miyazaki M, Okunishi H, Nishimura K, Toda N. Vascular angiotensin-converting enzyme activity in man and other species. Clin Sci 1984; 66: 39–45
- Miyazaki M, Okamura T, Okunishi H, Toda N. Vascular angiotensin converting enzyme in the development of renal hypertension. J Card Vase Pharmacol, (in press)